Iran unveils injectable anti-cancer drug

The Alborz-based company developed an injectable drug, dubbed “cyclophosphamide”, used in the treatment of many types of cancers.

The Iranian Vice-President for Science, Technology and Knowledge-Based Economy Ruhollah Dehghani Firouzabadi participated in the unveiling ceremony.

Referring to the effects of injection of the newly-developed medicine in the treatment of a wide spectrum of cancers, Firouzabadi stated that the drug is used to treat many diseases including ovarian cancer, breast cancer, blood cancer, and eye cancer.

He went on to say that the production of cyclophosphamide inside Iran and the patients’ sustainable access to this anti-cancer drug will be facilitated optimally from now on.

Provision and supply of anti-cancer drugs have always been one of the major concerns of the health officials and patients in Iran, the VP underlined.

Cyclophosphamide is reportedly used to treat cancers of the breast, blood and lymph system, and nerves (mainly in children).

Cyclophosphamide is also used for retinoblastoma, a type of eye cancer mainly in children, and multiple myeloma, a cancer in the bone marrow.

end / 107